Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Preventing mucopolysaccharidosis type II (Hunter syndrome): PGD and establishing a Hunter (46, XX) stem cell line.

Prenatal diagnosis - 1 Sept 2011

Altarescu Gheona, Renbaum Paul, Eldar-Geva Talia, Brooks Baruch, Varshaver Irit, Avitzour Mical, Margalioth Ehud J, Levy-Lahad Ephrat, Elstein Deborah, Epsztejn-Litman Silvina, Eiges Rachel

Abstract excerpt

OBJECTIVES: Preimplantation genetic diagnosis (PGD) enables the identification of affected embryos prior to implantation. We present for the first time three families in which either the oocytes or embryos obtained from female carriers of mutations in the iduronate-2-sulfatase (IDS) gene underwen...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blastomeres
Share to Embryo Culture Techniques

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Embryo Transfer

Share to Iduronate Sulfatase

Share to Mucopolysaccharidosis II

Share to Pregnancy Outcome

Share to Preimplantation Diagnosis

Share to Sperm Injections, Intracytoplasmic

Source

Identifiers

PMID: 21706504
DOI: 10.1002/pd.2786

Genes

PGD
IDS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21706504-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Preventing mucopolysaccharidosis type II (Hunter syndrome): PGD and establishing a Hunter (46, XX) stem cell line.PMID 21706504Read ↗

Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 1-year-old male with pathogenic IDS mutation.Semantic proximity Read ↗

Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 7-year-old male with pathogenic IDS mutation.Semantic proximity Read ↗

Generation of Mucopolysaccharidosis type II (MPS II) human induced pluripotent stem cell (iPSC) line from a 3-year-old male with pathogenic IDS mutation.Semantic proximity Read ↗

Generation of human induced pluripotent stem cell (iPSC) line from an unaffected female carrier of Mucopolysaccharidosis type II (MPS II) disorder.Semantic proximity Read ↗

Generation of an induced pluripotent stem cells line, CSSi014-A 9407, carrying the variant c.479C>T in the human iduronate 2-sulfatase (hIDS) gene.Semantic proximity Read ↗

Analysis of the IDS Gene in 38 Patients with Hunter Syndrome: The c.879G>A (p.Gln293Gln) Synonymous Variation in a Female Create Exonic SplicingSemantic proximity Read ↗

A versatile strategy for preimplantation genetic diagnosis of haemophilia A based on F8-gene sequencing.Semantic proximity Read ↗

Derivation of Huntington Disease affected Genea046 human embryonic stem cell line.Semantic proximity Read ↗

Derivation of FSHD1 affected human embryonic stem cell line Genea096.Semantic proximity Read ↗

The clinical application of single-sperm-based SNP haplotyping for PGD of osteogenesis imperfectaSemantic proximity Read ↗

Derivation of Huntington Disease affected Genea017 human embryonic stem cell line.Semantic proximity Read ↗

iPS-derived neural stem cells for disease modeling and evaluation of therapeutics for mucopolysaccharidosis type II.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.